Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Center for Bioavailability, Pharmaceutical, and Clinical Research (ICBR) is a leading Egyptian contract research organization (CRO) specializing in bioequivalence and bioavailability studies. Based in Obour City, Cairo, the center provides a comprehensive suite of analytical and clinical services to the pharmaceutical and biotechnology industries, ensuring compliance with EDA, EMA, and FDA standards. ICBR operates state-of-the-art laboratories for drug analysis, solubility testing, and quality verification, supported by GLP and GCP certifications. As a subsidiary of ACDIMA, the company plays a critical role in the regional drug development landscape by facilitating the registration and marketing of new medicinal products through rigorous clinical research and bioanalytical expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iCBR.